{
  "id": "mhgap#risk_safety_54b9a723",
  "content": "(https://doi.org/10.1192/bjp.2021.50).\n206. Prescribing information: SOLTAMOX®\n(tamoxifen citrate) oral solution. U.S. Food and 214. House A. Safety planning-type interventions for\nDrug Administration; revised 2018 (https:// suicide prevention: meta-analysis. Br J Psychiatry.\nwww.accessdata.fda.gov/drugsatfda_docs/ 2022;220(4):246 (https://doi.org/10.1192/\nlabel/2018/021807s005lbl.pdf). bjp.2021.197).\n207. Yildiz A, Siafis S, Mavridis D, Vieta E, Leucht 215. Ferguson M, Rhodes K, Loughhead M, McIntyre H,\nS. Comparative efficacy and tolerability of Procter N. The effectiveness of the safety planning\npharmacological interventions for acute bipolar intervention for adults experiencing suicide-\ndepression in adults: a systematic review and related distress: a systematic review. Arch Suicide\nnetwork meta-analysis. Lancet Psychiatry. Res. 2022;26(3):1022–45 (https://doi.org/10.1080/1\n2023;10(9):693–705 (https://doi.org/10.1016/ 3811118.2021.1915217).\nS2215-0366(23)00199-2).\n216. Stanley B, Brown GK. Safety planning intervention:\n208. Bighelli I, Salanti G, Huhn M, Schneider-Thoma a brief intervention to mitigate suicide risk. Cogn\nJ, Krause M, Reitmeir C et al. Psychological Behav Pract. 2012;19(2):256–64 (https://doi.\ninterventions to reduce positive symptoms in org/10.1016/j.cbpra.2011.01.001).\nschizophrenia: systematic review and network\nmeta-analysis. World Psychiatry. 2018;17(3):316–\n29 (https://doi.org/10.1002/wps.20577).\n128\nReferences\n217. Till B, Sonneck G, Baldauf G, Steiner E, 219. mhGAP training manuals for the mhGAP\nNiederkrotenthaler T. Reasons to love life. Effects intervention guide for mental, neurological and",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "high",
    "topics": [
      "stress",
      "work",
      "risk_safety",
      "screening_cues",
      "referral"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety (https://doi.org/10.1192/bjp.2021.50).\n206. Prescribing information: SOLTAMOX®\n(tamoxifen citrate) oral solution. U.S. Food and 214. House A. Safety planning-type interventions for\nDrug Administration; revised 2018 (https:// suicide prevention: meta-analysis. Br J Psychiatry.\nwww.accessdata.fda.gov/drugsatfda_docs/ 2022;220(4):246 (https://doi.org/10.1192/\nlabel/2018/021807s005lbl.pdf). bjp.2021.197).\n207. Yildiz A, Siafis S, Mavridis D, Vieta E, Leucht 215. Ferguson M, Rhodes K, Loughhead M, McIntyre H,\nS. Comparative efficacy and tolerability of Procter N. The effectiveness of the safety planning\npharmacological interventions for acute bipolar intervention for adults experiencing suicide-\ndepression in adults: a systematic review and related distress: a systematic review. Arch Suicide\nnetwork meta-analysis. Lancet Psychiatry. Res. 2022;26(3):1022–45 (https://doi.org/10.1080/1\n2023;10(9):693–705 (https://doi.org/10.1016/ 3811118.2021.1915217).\nS2215-0366(23)00199-2).\n216. Stanley B, Brown GK. Safety planning intervention:\n208. Bighelli I, Salanti G, Huhn M, Schneider-Thoma a brief intervention to mitigate suicide risk. Cogn\nJ, Krause M, Reitmeir C et al. Psychological Behav Pract. 2012;19(2):256–64 (https://doi.\ninterventions to reduce positive symptoms in org/10.1016/j.cbpra.2011.01.001).\nschizophrenia: systematic review and network\nmeta-analysis. World Psychiatry. 2018;17(3):316–\n29 (https://doi.org/10.1002/wps.20577).\n128\nReferences\n217. Till B, Sonneck G, Baldauf G, Steiner E, 219. mhGAP training manuals for the mhGAP\nNiederkrotenthaler T. Reasons to love life. Effects intervention guide for mental, neurological and (https://doi.org/10.1192/bjp.2021.50). 206."
}